+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Bromides 1421503-38-9
1421503-38-9,MFCD28291877
Catalog No.:AA009ICY

1421503-38-9 | 4-Bromo-5-ethyl-2-fluorophenol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$36.00   $26.00
- +
250mg
95%
in stock  
$85.00   $60.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA009ICY
Chemical Name:
4-Bromo-5-ethyl-2-fluorophenol
CAS Number:
1421503-38-9
Molecular Formula:
C8H8BrFO
Molecular Weight:
219.0509
MDL Number:
MFCD28291877
SMILES:
CCc1cc(O)c(cc1Br)F
Properties
Computed Properties
 
Complexity:
131  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
XLogP3:
3.2  

Downstream Synthesis Route

[1]CurrentPatentAssignee:PFIZERINC-WO2013/14567,2013,A1

[2]Jones,Peter;Storer,R.Ian;Sabnis,YogeshA.;Wakenhut,FlorianM.;Whitlock,GavinA.;England,KatherineS.;Mukaiyama,Takasuke;Dehnhardt,ChristophM.;Coe,JothamW.;Kortum,SteveW.;Chrencik,JillE.;Brown,DavidG.;Jones,RhysM.;Murphy,JohnR.;Yeoh,Thean;Morgan,Paul;Kilty,Iain[JournalofMedicinalChemistry,2017,vol.60,#2,p.767-786]

[3]CurrentPatentAssignee:HENANMEDINNOPHARMACEUTICALTECH;HENANMEDINNOPHARMACEUTICALTECHNOLOGY-CN111606908,2020,A

[4]Wellaway,ChristopherR.;Baldwin,IanR.;Bamborough,Paul;Barker,Daniel;Bartholomew,MichelleA.;Chung,Chun-Wa;Dümpelfeld,Birgit;Evans,JohnP.;Fazakerley,NealJ.;Homes,Paul;Keeling,StevenP.;Lewell,XiaoQ.;McNab,FinlayW.;Morley,Joanne;Needham,Deborah;Neu,Margarete;VanOosterhout,AntoonJ.M.;Pal,Anshu;Reinhard,FriedrichB.M.;Rianjongdee,Francesco;Robertson,CraigM.;Rowland,Paul;Shah,RishiR.;Sherriff,EmmaB.;Sloan,LisaA.;Teague,Simon;Thomas,DanielA.;Wellaway,Natalie;Wojno-Picon,Justyna;Woolven,JamesM.;Coe,DianeM.[JournalofMedicinalChemistry,2022,vol.65,#1,p.633-664]

[1]CurrentPatentAssignee:PFIZERINC-WO2013/14567,2013,A1Locationinpatent:Page/Pagecolumn65

[2]Jones,Peter;Storer,R.Ian;Sabnis,YogeshA.;Wakenhut,FlorianM.;Whitlock,GavinA.;England,KatherineS.;Mukaiyama,Takasuke;Dehnhardt,ChristophM.;Coe,JothamW.;Kortum,SteveW.;Chrencik,JillE.;Brown,DavidG.;Jones,RhysM.;Murphy,JohnR.;Yeoh,Thean;Morgan,Paul;Kilty,Iain[JournalofMedicinalChemistry,2017,vol.60,#2,p.767-786]

[3]Wellaway,ChristopherR.;Baldwin,IanR.;Bamborough,Paul;Barker,Daniel;Bartholomew,MichelleA.;Chung,Chun-Wa;Dümpelfeld,Birgit;Evans,JohnP.;Fazakerley,NealJ.;Homes,Paul;Keeling,StevenP.;Lewell,XiaoQ.;McNab,FinlayW.;Morley,Joanne;Needham,Deborah;Neu,Margarete;VanOosterhout,AntoonJ.M.;Pal,Anshu;Reinhard,FriedrichB.M.;Rianjongdee,Francesco;Robertson,CraigM.;Rowland,Paul;Shah,RishiR.;Sherriff,EmmaB.;Sloan,LisaA.;Teague,Simon;Thomas,DanielA.;Wellaway,Natalie;Wojno-Picon,Justyna;Woolven,JamesM.;Coe,DianeM.[JournalofMedicinalChemistry,2022,vol.65,#1,p.633-664]

[4]CurrentPatentAssignee:HENANMEDINNOPHARMACEUTICALTECH;HENANMEDINNOPHARMACEUTICALTECHNOLOGY-CN111606908,2020,ALocationinpatent:Paragraph0508;0517;0565-0567

[1]CurrentPatentAssignee:PFIZERINC-WO2013/14567,2013,A1Locationinpatent:Page/Pagecolumn54

[2]Jones,Peter;Storer,R.Ian;Sabnis,YogeshA.;Wakenhut,FlorianM.;Whitlock,GavinA.;England,KatherineS.;Mukaiyama,Takasuke;Dehnhardt,ChristophM.;Coe,JothamW.;Kortum,SteveW.;Chrencik,JillE.;Brown,DavidG.;Jones,RhysM.;Murphy,JohnR.;Yeoh,Thean;Morgan,Paul;Kilty,Iain[JournalofMedicinalChemistry,2017,vol.60,#2,p.767-786]

[3]CurrentPatentAssignee:HENANMEDINNOPHARMACEUTICALTECH;HENANMEDINNOPHARMACEUTICALTECHNOLOGY-CN111606908,2020,ALocationinpatent:Paragraph0508;0517;0562-0564

[4]CurrentPatentAssignee:HENANMEDINNOPHARMACEUTICALTECH;HENANMAIYINGNUOPHARMACEUTICALTECH-WO2022/33563,2022,A1Locationinpatent:Page/Pagecolumn26;28-29

[5]Wellaway,ChristopherR.;Baldwin,IanR.;Bamborough,Paul;Barker,Daniel;Bartholomew,MichelleA.;Chung,Chun-Wa;Dümpelfeld,Birgit;Evans,JohnP.;Fazakerley,NealJ.;Homes,Paul;Keeling,StevenP.;Lewell,XiaoQ.;McNab,FinlayW.;Morley,Joanne;Needham,Deborah;Neu,Margarete;VanOosterhout,AntoonJ.M.;Pal,Anshu;Reinhard,FriedrichB.M.;Rianjongdee,Francesco;Robertson,CraigM.;Rowland,Paul;Shah,RishiR.;Sherriff,EmmaB.;Sloan,LisaA.;Teague,Simon;Thomas,DanielA.;Wellaway,Natalie;Wojno-Picon,Justyna;Woolven,JamesM.;Coe,DianeM.[JournalofMedicinalChemistry,2022,vol.65,#1,p.633-664]

1421503-38-9    100-39-0   
1-(benzyloxy)-4-bromo-5-ethyl-2-fluorobenzene 

[1]CurrentPatentAssignee:GOSSAMERBIOSERVICES-WO2022/109492,2022,A1Locationinpatent:Page/Pagecolumn504;505

[2]CurrentPatentAssignee:GOSSAMERBIOSERVICES-WO2022/109492,2022,A1Locationinpatent:Page/Pagecolumn504;505

[3]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-WO2018/165392,2018,A1Locationinpatent:Page/Pagecolumn35;36

[4]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2020/71323,2020,A1Locationinpatent:Paragraph0173-0174

[5]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2021/269437,2021,A1Locationinpatent:Paragraph0218-0219

[6]CurrentPatentAssignee:HENANMEDINNOPHARMACEUTICALTECH;HENANMAIYINGNUOPHARMACEUTICALTECH-WO2022/33563,2022,A1Locationinpatent:Page/Pagecolumn26;28-29

[7]CurrentPatentAssignee:PFIZERINC-US2015/329542,2015,A1Locationinpatent:Paragraph0757

[8]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-WO2017/79205,2017,A1Locationinpatent:Page/Pagecolumn38

1421503-38-9   
C29H40FN3O4SSi 

[1]Ritzén,Andreas;Sørensen,MortenD.;Dack,KevinN.;Greve,DanielR.;Jerre,Anders;Carnerup,MartinA.;Rytved,KlausA.;Bagger-Bahnsen,Jesper[ACSMedicinalChemistryLetters,2016,vol.7,#6,p.641-646]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1421503-38-9
550400-07-2

550400-07-2

 1825306-64-6

1825306-64-6
Building Blocks
More >
Tags:1421503-38-9 Molecular Formula|1421503-38-9 MDL|1421503-38-9 SMILES|1421503-38-9 4-Bromo-5-ethyl-2-fluorophenol